These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6112116)

  • 1. Clopenthixol decanoate in schizophrenia.
    Carney MW; Rutherford P
    Curr Med Res Opin; 1981; 7(4):205-11. PubMed ID: 6112116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 5-year follow-up study of chronic schizophrenics treated with clopenthixol decanoate.
    Carney MW
    Pharmatherapeutica; 1984; 4(1):57-63. PubMed ID: 6150493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients.
    Walker CA
    Pharmatherapeutica; 1983; 3(5):289-93. PubMed ID: 6133287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term treatment of chronic schizophrenics with clopenthixol decanoate.
    Borsetti G; Rocco P; Spilimbergo PG; Giavedoni A; Frangiamone L; Beccaceci A; Judice A; Cisternino M; Volterra V
    Pharmatherapeutica; 1984; 4(1):53-6. PubMed ID: 6150492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clopenthixol decanoate in the treatment of chronic schizophrenic in-patients.
    Viswanathan R; Rajhkowa S
    Pharmatherapeutica; 1982; 3(2):93-9. PubMed ID: 7100227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance treatment of chronic schizophrenic patients. A study with the long-acting thioxanthene derivative, cis(Z)-clopenthixol decanoate-sordinol depot.
    Dom R; De Mesmaecker L; van den Broucke M; van Hest T; Baro F
    Acta Psychiatr Scand; 1978 Apr; 57(4):299-304. PubMed ID: 352094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A new injectable delayed-action neuroleptic with sedative and antipsychotic action: cis-(Z)-clopenthixol decanoate. Clinical trials].
    Lambert PA; Chabannes JP
    Encephale; 1984; 10(2):83-91. PubMed ID: 6381033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [cis(Z)-Clopenthixol decanoate--a new depot neuroleptic].
    Sieberns S; Spechtmeyer H
    Int Pharmacopsychiatry; 1982; 17(3):170-84. PubMed ID: 7141812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A 1-year experience with the administration of clopenthixol decanoate in schizophrenic psychoses].
    Svestka J; Náhunek K; Cesková E; Rysánek R
    Cesk Psychiatr; 1984 Jun; 80(3):146-54. PubMed ID: 6148152
    [No Abstract]   [Full Text] [Related]  

  • 10. An open clinical trial with the long-acting neuroleptic zuclopenthixol decanoate in the maintenance treatment of schizophrenia.
    Kazi HA
    Pharmatherapeutica; 1986; 4(9):555-60. PubMed ID: 3763650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clopenthixol decanoate and perphenazine enanthate in schizophrenic patients. A double-blind Nordic multicentre trial.
    Ahlfors UG; Dencker SJ; Gravem A; Remvig J
    Acta Psychiatr Scand Suppl; 1980; 279():77-91. PubMed ID: 6996426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Maintenance therapy using clopenthixol decanoate in schizophrenic patients].
    Kabes J; Balon R; Papezová H
    Cesk Psychiatr; 1986 Aug; 82(3-4):189-94. PubMed ID: 3769007
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experience with Cis-(Z-)Clopenthixol-Decanoate (Sordinol-Depot) (author's transl)].
    Zmorski T; Unterrassner R
    Schweiz Rundsch Med Prax; 1979 Nov; 68(48):1605-9. PubMed ID: 538008
    [No Abstract]   [Full Text] [Related]  

  • 14. Zuclopenthixol decanoate and haloperidol decanoate in chronic schizophrenia: a double-blind multicentre study.
    Wistedt B; Koskinen T; Thelander S; Nerdrum T; Pedersen V; Mølbjerg C
    Acta Psychiatr Scand; 1991 Jul; 84(1):14-21. PubMed ID: 1681680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zuclopenthixol decanoate in schizophrenia: serum levels and clinical state.
    Jørgensen A; Aaes-Jørgensen T; Gravem A; Amthor KF; Dencker SJ; Rosell I; Baastrup PC; Buckhave J; Gram LF
    Psychopharmacology (Berl); 1985; 87(3):364-7. PubMed ID: 2867572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open multicentre trial of zuclopenthixol in mania and schizophrenia based on the AMDP scales.
    Bobon D; Troisfontaines B; Kempeneers JL; Xhenseval B; Bourdouxhe S; Mirel J; Gilson H; Toussaint C; von Frenckell R; Pedersen V
    Acta Psychiatr Belg; 1986; 86(2):152-76. PubMed ID: 2873713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical assessment of zuclopenthixol dihydrochloride (Clopixol tablets) in the treatment of psychotic illness.
    Mann BS; Moslehuddin KS; Owen RT; Clayton AR; Rohatgi KK; Sud P; Vaddadi KS
    Pharmatherapeutica; 1985; 4(6):387-92. PubMed ID: 2867559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. I. A one year double-blind study of clopenthixol decanoate and flupenthixol palmitate.
    Dencker SJ; Lepp M; Malm U
    Acta Psychiatr Scand Suppl; 1980; 279():10-28. PubMed ID: 6931470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A specific method for assay of drug levels in serum of patients treated with clopenthixol decanoate injections.
    Overø KF
    Acta Psychiatr Scand Suppl; 1980; 279():92-103. PubMed ID: 6931474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The decanoates of flupenthixol and clopenthixol in the treatment of chronic schizophrenic in-patients. Implications for community psychiatry.
    Martyns-Yellowe IS
    West Afr J Med; 1993; 12(2):110-3. PubMed ID: 8104468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.